Brittany Bradrick
CIK: 0001904176
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DRMA
Dermata Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Bradrick Brittany
Bradrick Brittany (SEC CIK 0001904176) files insider reports with the SEC as Director of Dermata Therapeutics, Inc. (DRMA).
Signal8 holds 2 ownership filings by Bradrick Brittany, all Form 4s, filed between Jan 14, 2025 and Jan 6, 2026. Those filings report 2 transactions, from Jan 13, 2025 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bradrick Brittany's filings is in SAN DIEGO, CA.
Recent filings by Bradrick Brittany
Other insiders filing for Dermata Therapeutics, Inc. (DRMA)
- PROEHL GERALD T, PRESIDENT, CHAIRMAN, CEO
- Van Hoose Kyri K., SVP, CFO
- Scott Kathleen D., Director
- Bedoya-Toro Munera Maria E, SVP, Regulatory Affairs
- WIERENGA WENDELL, Director
- HALE DAVID F, Director